NSW Health advice regarding pneumococcal vaccine and coronavirus

6 April 2020


NSW Health has sent the following information via email to all immunisation providers in NSW registered with the NSW Vaccine Centre.

Pneumococcal vaccine and coronavirus (COVID-19)

  • NSW Health has noted an increase in distribution of pneumococcal vaccines and has received reports that pneumococcal vaccines are being administered to healthy people to protect them against COVID-19.
  • Pneumococcal vaccines (Pneumovax 23 and Prevenar 13) protect against disease such as pneumonia caused specifically by the bacterium Pneumococcal vaccines will not provide protection against COVID-19. There is currently no evidence to suggest that pneumococcal vaccines provide protection against COVID-19 associated pneumonia.
  • Pneumococcal vaccination is not recommended for healthy adolescents and adults due to their low disease risk. Government funded vaccine should only be used for those particularly vulnerable to pneumococcal infection. These include all:
    • Young children at 6 weeks, 4 months and 12 months of age, medically at risk children should receive an additional dose at 6 months of age
    • Aboriginal people 15 - 49 years with underlying risk conditions associated with pneumococcal disease.
    • Aboriginal people 50 years and over
    • Older adults 65 years and over
  • Restrictions have been placed on the amount of pneumococcal vaccines that can be ordered to maintain adequate supply for eligible cohorts.

Keep up to date with Immunisation information on our PHN Immunisation webpage
Keep up to date with coronavirus information on our PHN Coronavirus webpage.